NEJM Evidence Issues Research Articles in May 2023 Edition
May 20, 2023
May 20, 2023
WALTHAM, Massachusetts, May 20 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its May 2023 edition:
Original Articles:
* Intraperitoneal Carboplatin for Ovarian Cancer -- A Phase 2/3 Trial
* Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen
* Prediction of Risk f . . .
Original Articles:
* Intraperitoneal Carboplatin for Ovarian Cancer -- A Phase 2/3 Trial
* Meta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen
* Prediction of Risk f . . .
